Olga Abramczyk

634 total citations
14 papers, 536 citations indexed

About

Olga Abramczyk is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Olga Abramczyk has authored 14 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Cell Biology and 2 papers in Organic Chemistry. Recurrent topics in Olga Abramczyk's work include Protein Kinase Regulation and GTPase Signaling (7 papers), Melanoma and MAPK Pathways (6 papers) and Cellular Mechanics and Interactions (2 papers). Olga Abramczyk is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (7 papers), Melanoma and MAPK Pathways (6 papers) and Cellular Mechanics and Interactions (2 papers). Olga Abramczyk collaborates with scholars based in United States, Poland and Hong Kong. Olga Abramczyk's co-authors include Kevin N. Dalby, James T. Murray, Ashwini K. Devkota, Kari Callaway, Lance Martin, Mangalika Warthaka, Tamer S. Kaoud, Austen Riggs, Francesca M. Buffa and Dean C. Singleton and has published in prestigious journals such as Biochemistry, Cancer Research and Biochemical Journal.

In The Last Decade

Olga Abramczyk

14 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Abramczyk United States 13 400 110 91 54 51 14 536
Dale Corkery Sweden 13 297 0.7× 70 0.6× 113 1.2× 47 0.9× 63 1.2× 28 508
Yuzhu Zheng China 10 275 0.7× 91 0.8× 47 0.5× 59 1.1× 129 2.5× 15 450
Chido Mpamhanga United Kingdom 7 259 0.6× 314 2.9× 104 1.1× 56 1.0× 32 0.6× 11 499
Ilaria Lamberto United States 14 454 1.1× 40 0.4× 106 1.2× 23 0.4× 143 2.8× 18 656
Shinmee Mah South Korea 9 369 0.9× 33 0.3× 58 0.6× 41 0.8× 82 1.6× 13 597
Nadav Askari Israel 9 304 0.8× 30 0.3× 47 0.5× 39 0.7× 72 1.4× 10 440
Seung‐Keun Hong United States 16 471 1.2× 110 1.0× 102 1.1× 69 1.3× 107 2.1× 28 603
Gregor M. Balaburski United States 9 289 0.7× 181 1.6× 69 0.8× 70 1.3× 70 1.4× 10 433
Anette Wärnmark Sweden 9 448 1.1× 42 0.4× 27 0.3× 32 0.6× 97 1.9× 11 743

Countries citing papers authored by Olga Abramczyk

Since Specialization
Citations

This map shows the geographic impact of Olga Abramczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Abramczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Abramczyk more than expected).

Fields of papers citing papers by Olga Abramczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Abramczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Abramczyk. The network helps show where Olga Abramczyk may publish in the future.

Co-authorship network of co-authors of Olga Abramczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Abramczyk. A scholar is included among the top collaborators of Olga Abramczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Abramczyk. Olga Abramczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jabłońska, Anna, Olga Abramczyk, Martyna Poprzeczko, et al.. (2024). Abstract 3184: Development of an innovative bifunctional CPL976-MMAE conjugate based on a bispecific anti-PD-L1/ant-AXL antibody with a dual mechanism of action. Cancer Research. 84(6_Supplement). 3184–3184. 1 indexed citations
2.
Yuen, Hiu‐Fung, Olga Abramczyk, Yuhan Huang, et al.. (2012). Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells. Bioscience Reports. 32(4). 413–422. 26 indexed citations
3.
Pike, Luke, Dean C. Singleton, Francesca M. Buffa, et al.. (2012). Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival. Biochemical Journal. 449(2). 389–400. 126 indexed citations
4.
Devkota, Ashwini K., Clint D.J. Tavares, Mangalika Warthaka, et al.. (2012). Investigating the Kinetic Mechanism of Inhibition of Elongation Factor 2 Kinase by NH125: Evidence of a Common in Vitro Artifact. Biochemistry. 51(10). 2100–2112. 51 indexed citations
5.
Tavares, Clint D.J., John P. OʼBrien, Olga Abramczyk, et al.. (2012). Calcium/Calmodulin Stimulates the Autophosphorylation of Elongation Factor 2 Kinase on Thr-348 and Ser-500 To Regulate Its Activity and Calcium Dependence. Biochemistry. 51(11). 2232–2245. 53 indexed citations
6.
McCaig, Catherine, et al.. (2011). Phosphorylation of NDRG1 is temporally and spatially controlled during the cell cycle. Biochemical and Biophysical Research Communications. 411(2). 227–234. 41 indexed citations
7.
Abramczyk, Olga, Clint D.J. Tavares, Ashwini K. Devkota, et al.. (2011). Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli. Protein Expression and Purification. 79(2). 237–244. 25 indexed citations
8.
Piserchio, Andrea, Mangalika Warthaka, Ashwini K. Devkota, et al.. (2011). Solution NMR Insights into Docking Interactions Involving Inactive ERK2. Biochemistry. 50(18). 3660–3672. 35 indexed citations
9.
Kaoud, Tamer S., Ashwini K. Devkota, Richard Harris, et al.. (2011). Activated ERK2 Is a Monomer in Vitro with or without Divalent Cations and When Complexed to the Cytoplasmic Scaffold PEA-15. Biochemistry. 50(21). 4568–4578. 32 indexed citations
10.
Abramczyk, Olga, Mark A. Rainey, Richard H. Barnes, Lance Martin, & Kevin N. Dalby. (2007). Expanding the Repertoire of an ERK2 Recruitment Site:  Cysteine Footprinting Identifies the D-Recruitment Site as a Mediator of Ets-1 Binding. Biochemistry. 46(32). 9174–9186. 30 indexed citations
11.
Callaway, Kari, Olga Abramczyk, Lance Martin, & Kevin N. Dalby. (2007). The Anti-Apoptotic Protein PEA-15 Is a Tight Binding Inhibitor of ERK1 and ERK2, Which Blocks Docking Interactions at the D-Recruitment Site. Biochemistry. 46(32). 9187–9198. 47 indexed citations
12.
Callaway, Kari, Mark A. Rainey, Austen Riggs, Olga Abramczyk, & Kevin N. Dalby. (2006). Properties and Regulation of a Transiently Assembled ERK2·Ets-1 Signaling Complex. Biochemistry. 45(46). 13719–13733. 41 indexed citations
13.
Abramczyk, Olga, et al.. (2003). TBBz but not TBBt discriminates between two molecular forms of CK2 in vivo and its implications. Biochemical and Biophysical Research Communications. 312(3). 623–628. 13 indexed citations
14.
Abramczyk, Olga, et al.. (2003). The protein kinase 60S is a free catalytic CK2α′ subunit and forms an inactive complex with superoxide dismutase SOD1. Biochemical and Biophysical Research Communications. 307(1). 31–40. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026